U.S. Biotech Stock News

ECB Bancorp’s FY 2025 earnings step up as margins strengthen ECB Bancorp (ECBK) has just wrapped up FY 2025 with fourth quarter total revenue of US$9.3 million and basic EPS of US$0.32, supported by quarterly net income of US$2.6 million. The company has seen total revenue move from US$7.4 million in Q4 2024 to US$9.3 million in Q4 2025, while basic EPS has shifted from US$0.18 to US$0.32 over the same period, alongside trailing twelve month net income of US$7.8 million. For investors, the...

Why Clear Secure Is Suddenly in the Spotlight Clear Secure (YOU) has jumped up investors’ watchlists after a run of quarters where it beat both earnings and revenue expectations, drawing fresh media coverage and interest in its recent stock moves. See our latest analysis for Clear Secure. Despite a 44.92% total shareholder return over the past year, recent share price performance has cooled. The 30 day share price return is 9.30% and the 90 day share price return is 9.67%, which hints that...

Brown & Brown (BRO) is in focus after reporting full year 2025 results, along with the announcement of Chief Legal Officer Robert Mathis’s passing and the appointment of Eileen Akerson as interim successor. See our latest analysis for Brown & Brown. The earnings release and leadership change landed after a weaker patch for the shares, with a 30 day share price return of 9.47% and a 1 year total shareholder return decline of 32.07%. However, the 3 and 5 year total shareholder returns of 27.14%...

Fiserv (NasdaqGS:FISV) has expanded its collaboration with Affirm to bring pay over time features to debit cards. The partnership gives thousands of U.S. banks and credit unions access to Affirm powered buy now, pay later (BNPL) within their existing apps. Customers of participating issuers can use BNPL directly through their debit cards and tap into Affirm’s merchant network. Fiserv, a major provider of payments and financial technology, is responding to BNPL demand by embedding Affirm’s...

In recent days, Asana reported past progress on tightening financial discipline and raised its full-year revenue and operating margin guidance while operating in a constrained growth backdrop. A key takeaway is Asana’s push into AI-powered offerings like AI Studio and AI Teammates, which could gradually shift its business toward a more consumption-oriented model less tied to traditional seat expansion. Next, we’ll examine how Asana’s focus on AI-driven products and evolving monetization...

MPLX LP recently reported higher fourth quarter and full-year 2025 revenue and net income, continued its unit repurchase program, affirmed its quarterly cash distribution of US$1.0765 per common unit, and announced a new fixed-rate senior unsecured notes offering to support future investments. Alongside these results, management highlighted an ongoing focus on natural gas and NGL infrastructure projects and a disciplined approach to potential M&A, pointing to a capital plan centered on...

New Jersey Resources Corporation recently reported past first-quarter fiscal 2026 results, with revenue of US$604.85 million and net income of US$122.49 million, and raised its fiscal 2026 net financial earnings per share guidance to US$3.28–US$3.43 following strong Energy Services performance amid natural gas price volatility and extreme winter weather. Management’s updated outlook, combined with plans to invest about US$5 billion through 2030 across its regulated utility, storage and...

Investor caution around margins and crude volatility Recent commentary on Delek US Holdings (DK) highlights investors growing more cautious as crude price swings and uncertain refining margins keep near term cash flow visibility in question. Management is responding by leaning into operational efficiency, tighter cost control, and more selective capital allocation. This approach puts the focus on existing assets rather than large scale capacity expansion for now. See our latest analysis for...

Alexandria Real Estate Equities, Inc. reported fourth-quarter 2025 results showing revenue of US$754.41 million and a net loss of US$1.08 billion, driven largely by a real estate impairment charge of about US$1.72 billion. For 2025 as a whole, Alexandria moved from net income in the prior year to a net loss of about US$1.43 billion, sharply altering how investors may assess the resilience of its real estate portfolio and balance sheet. Next, we will examine how this large real estate...

Agilent Technologies (A) is putting automation, imaging, and AI tools front and center at the SLAS2026 conference in Boston, previewing new platforms aimed at workflow efficiency and regulatory compliance in pharma and biotech labs. See our latest analysis for Agilent Technologies. Despite the automation and AI product momentum, Agilent’s recent trading has been weaker, with a 30 day share price return of a 12.17% decline and a 1 year total shareholder return of an 11.48% decline, pointing to...

Recent share performance context Teradata (TDC) has drawn attention after a period of weaker share performance, with the stock down over the past month and past 3 months. This has prompted investors to reassess expectations and current valuation. See our latest analysis for Teradata. At a share price of US$26.75, Teradata’s recent momentum has been weak, with a 30 day share price return of a 13.96% decline and a 1 year total shareholder return of a 13.15% decline, pointing to fading...

YETI Holdings (YETI) is back in focus as investors look ahead to its upcoming full year results, weighing the company’s exit from manufacturing in China and its push into soft coolers and bags. See our latest analysis for YETI Holdings. YETI’s share price has had a mixed year, with a recent 27.01% 90 day share price return contrasted against a 35.80% decline over five years on a total shareholder return basis. This suggests near term momentum but a weaker long run track record. If YETI’s...

International Business Machines (IBM) is back in focus after reporting Q4 results with higher revenue and net income year over year, along with a new role supporting the U.S. Missile Defense Agency’s SHIELD program. See our latest analysis for International Business Machines. IBM’s share price has pulled back recently, with a 7 day share price return of 6.26% and a 30 day share price return of 4.16%. At the same time, the 1 year total shareholder return sits at 17.34% and the 5 year total...

If you are wondering whether LCI Industries is fairly priced or offering value right now, you are not alone. This article will walk through the key numbers that matter. The stock last closed at US$152.75, with returns of 2.3% over 7 days, 20.8% over 30 days, 22.9% year to date, 57.8% over 1 year, 49.1% over 3 years and 26.7% over 5 years. This naturally raises questions about what is already reflected in the current price. Recent coverage of LCI Industries has focused on how investors are...

BorgWarner (NYSE:BWA) declared a quarterly cash dividend, reaffirming its regular payout to shareholders. The board approval signals continued capital return through ongoing dividend distributions. BorgWarner focuses on powertrain and eMobility solutions for global automakers, with products that span combustion, hybrid, and electric vehicle technologies. For investors watching the auto components space, dividend decisions can be especially relevant as manufacturers and suppliers adjust...

Amphastar Pharmaceuticals recently reported that rising day-to-day expenses have outpaced revenue, causing its adjusted operating margin to contract by 4.3 percentage points. This margin pressure is particularly important for Amphastar, which operates with a relatively small revenue base and fewer distribution channels than larger drugmakers. We’ll examine how this adjusted operating margin compression shapes Amphastar’s investment narrative, particularly around cost control and operational...

MiroliverELAP trial update and why it matters for United Therapeutics (UTHR) United Therapeutics (UTHR) recently reported positive safety and survival findings from a phase 1 study of miroliverELAP, an external liver assist device for acute liver failure patients who are not eligible for transplants. The single arm, open label trial treated five such patients continuously for at least 44 hours. It met its primary survival endpoint during treatment and reported no unexpected serious adverse...

Kimball Electronics (KE) has put out a mixed Q2 2026 update, with revenue of US$341.3 million and basic EPS of US$0.15, alongside trailing twelve month EPS of US$0.98 on US$1.46 billion of revenue that reflects a sharp 199.5% earnings gain over the last year but a longer run of choppy results. The company has seen quarterly revenue move between US$341.3 million and US$380.5 million over the past six reported periods, while basic EPS has ranged from about US$0.13 to US$0.41. This sets the...

In late January 2026, Motorola Solutions launched Assist Suites, a portfolio of role-based AI tools that unify 911 audio, video, radio transcripts and other data to support faster emergency response, officer safety and more accurate reporting for public safety agencies. A key feature, Narrative Assist, cross-references an officer’s account with multiple verified data sources, highlighting discrepancies while preserving human oversight and a full audit trail, which could influence how...

Why Unum Group (UNM) Is On Investors’ Radar Today Unum Group (UNM) is drawing fresh attention after recent share price moves, with the stock showing negative returns over the past week, month, and past 3 months, and a modest positive total return over the past year. See our latest analysis for Unum Group. At a share price of US$75.66, Unum Group’s recent 7 day and 90 day share price returns of 0.83% and 3.19% declines contrast with a 1 year total shareholder return of 0.99% and very strong 3...

Recent share performance and business snapshot Trade Desk (TTD) has seen a series of sharp pullbacks, with the share price down about 4% over the past day and weaker returns over the week, month and past 3 months. The stock is also showing negative year to date and 1 year total returns, despite the company reporting annual revenue of US$2.79b and net income of US$438.58m from its global advertising technology platform. See our latest analysis for Trade Desk. With the share price at US$26.24,...

Edwards Lifesciences (NYSE:EW) is awaiting an FDA decision on its SAPIEN M3 Transcatheter Mitral Valve Replacement system, a potential milestone for its structural heart portfolio. Institutional investors have been building positions around this catalyst, with recent order flow suggesting heightened attention on the upcoming regulatory outcome. The company has also been active with a share repurchase program, signaling confidence from management in the long term outlook. Edwards...

Pentair plc recently reported past fourth-quarter and full-year 2025 results showing higher sales and earnings per share, while also issuing new 2026 guidance and outlining only minor asset impairments of US$600,000. Alongside this, the company unveiled a reshaped leadership structure that elevates digital and AI-focused innovation while eliminating long-standing supply chain and technology officer roles, signaling a shift in how it pursues growth and execution. We’ll now examine how...

Blue Bird (BLBD) has opened fiscal 2026 with Q1 revenue of US$333.1 million and basic EPS of US$0.97, alongside trailing twelve month revenue of about US$1.5 billion and EPS of US$4.09 that reflects a 20% earnings lift over the past year. Over recent quarters, the company has seen revenue move from US$313.9 million in Q1 2025 to US$333.1 million in Q1 2026, while basic EPS shifted from US$0.89 to US$0.97 as net profit margin held in the high single digits. With net profit margin edging up to...